|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Piazuelo MB and Correa P: Gastric cancer:
Overview. Colomb Med (Cali). 44:192–201. 2013.PubMed/NCBI
|
|
4
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang X, Cai D, Meng L and Wang B:
MicroRNA-124 inhibits proliferation, invasion, migration and
epithelial-mesenchymal transition of cervical carcinoma cells by
targeting astrocyte-elevated gene-1. Oncol Rep. 36:2321–2328. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu K, He Y, Xia C, Yan J, Hou J, Kong D,
Yang Y and Zheng G: MicroRNA-15a inhibits proliferation and induces
apoptosis in CNE1 nasopharyngeal carcinoma cells. Oncol Res.
24:145–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang G, Fu Y, Liu G, Ye Y and Zhang X:
miR-218 inhibits proliferation, migration, and EMT of gastric
cancer cells by targeting WASF3. Oncol Res. 25:355–364. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lv H, Zhang Z, Wang Y, Li C, Gong W and
Wang X: MicroRNA-92a promotes colorectal cancer cell growth and
migration by inhibiting KLF4. Oncol Res. 23:283–290. 2016.
View Article : Google Scholar
|
|
11
|
Liu X, Li J, Yu Z, Sun R and Kan Q:
MiR-935 promotes liver cancer cell proliferation and migration by
targeting SOX7. Oncol Res. 25:427–435. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li X, Li Y and Lu H: MiR-1193 suppresses
proliferation and invasion of human breast cancer cells through
directly targeting IGF2BP2. Oncol Res. 25:579–585. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu P, Wang C, Ma C, Wu Q, Zhang W and Lao
G: MicroRNA-23a regulates epithelial-to-mesenchymal transition in
endometrial endometrioid adenocarcinoma by targeting SMAD3. Cancer
Cell Int. 16:672016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He Y, Meng C, Shao Z, Wang H and Yang S:
MiR-23a functions as a tumor suppressor in osteosarcoma. Cell
Physiol Biochem. 34:1485–1496. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu LH, Liu T, Tang H, Tian RQ, Su C, Liu
M and Li X: MicroRNA-23a promotes the growth of gastric
adenocarcinoma cell line MGC803 and downregulates interleukin-6
receptor. FEBS J. 277:3726–3734. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu X, Liu Q, Fan Y, Wang S, Liu X, Zhu L,
Liu M and Tang H: Downregulation of PPP2R5E expression by miR-23a
suppresses apoptosis to facilitate the growth of gastric cancer
cells. FEBS Lett. 588:3160–3169. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lim J, Wong ES, Ong SH, Yusoff P, Low BC
and Guy GR: Sprouty proteins are targeted to membrane ruffles upon
growth factor receptor tyrosine kinase activation. Identification
of a novel translocation domain. J Biol Chem. 275:32837–32845.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lim J, Yusoff P, Wong ES, Chandramouli S,
Lao DH, Fong CW and Guy GR: The cysteine-rich sprouty translocation
domain targets mitogen-activated protein kinase inhibitory proteins
to phosphatidylinositol 4,5-bisphosphate in plasma membranes. Mol
Cell Biol. 22:7953–7966. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu C, Liang S, Xiao S, Lin Q, Chen X, Wu
Y and Fu J: MicroRNA-27b inhibits Spry2 expression and promotes
cell invasion in glioma U251 cells. Oncol Lett. 9:1393–1397. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chandramouli S, Yu CY, Yusoff P, Lao DH,
Leong HF, Mizuno K and Guy GR: Tesk1 interacts with Spry2 to
abrogate its inhibition of ERK phosphorylation downstream of
receptor tyrosine kinase signaling. J Biol Chem. 283:1679–1691.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu G, Qin XQ, Guo JJ, Li TY and Chen JH:
AKT/ERK activation is associated with gastric cancer cell
resistance to paclitaxel. Int J Clin Exp Pathol. 7:1449–1458.
2014.PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Dalta Dalta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yim DG, Ghosh S, Guy GR and Virshup DM:
Casein kinase 1 regulates Sprouty2 in FGF-ERK signaling. Oncogene.
34:474–484. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deng J, Lei W, Xiang X, Zhang L, Yu F,
Chen J, Feng M and Xiong J: MicroRNA-506 inhibits gastric cancer
proliferation and invasion by directly targeting Yap1. Tumour Biol.
36:6823–6831. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu WD, Zuo Y, Xu Z and Zhang M: MiR-19a
promotes epithelial-mesenchymal transition through PI3K/AKT pathway
in gastric cancer. World J Gastroenterol. 21:4564–4573. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li QL, Yang Y, Zhang L, Chen H, Pan D and
Xie WJ: MicroRNA-181b inhibits glycolysis in gastric cancer cells
via targeting hexokinase 2 gene. Cancer Biomark. 17:75–81. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li X, Zhang Y, Zhang H, Liu X, Gong T, Li
M, Sun L, Ji G, Shi Y, Han Z, et al: miRNA-223 promotes gastric
cancer invasion and metastasis by targeting tumor suppressor
EPB41L3. Mol Cancer Res. 9:824–833. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
An J, Pan Y, Yan Z, Li W, Cui J, Yuan J,
Tian L, Xing R and Lu Y: MiR-23a in amplified 19p13.13 loci targets
metallothionein 2A and promotes growth in gastric cancer cells. J
Cell Biochem. 114:2160–2169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma G, Dai W, Sang A, Yang X and Gao C:
Upregulation of microRNA-23a/b promotes tumor progression and
confers poor prognosis in patients with gastric cancer. Int J Clin
Exp Pathol. 7:8833–8840. 2014.PubMed/NCBI
|
|
30
|
Zhu L, Tian J, Chen L, Wang M, Xiong Y,
Zhang G, Li S and Yuan L: Effect of blocking endogenous miR-23a on
the proliferation and invasion in gastric adenocarcinoma cell line
MGC803. Nan Fang Yi Ke Da Xue Xue Bao. 33:678–683. 2013.(In
Chinese). PubMed/NCBI
|
|
31
|
Mei Y, Bian C, Li J, Du Z, Zhou H, Yang Z
and Zhao RC: miR-21 modulates the ERK-MAPK signaling pathway by
regulating SPRY2 expression during human mesenchymal stem cell
differentiation. J Cell Biochem. 114:1374–1384. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiang J, Yi B, Qin C, Ding S and Cao W:
Upregulation of microRNA27b contributes to the migration and
invasion of gastric cancer cells via the inhibition of
sprouty2-mediated ERK signaling. Mol Med Rep. 13:2267–2272. 2016.
View Article : Google Scholar : PubMed/NCBI
|
